Curiosity Driven, Excellence Focused, Patient Centered
At Tiefenbacher Group, we believe that our expertise must be leveraged for the greater good – to improve patients’ lives worldwide by pioneering healthcare. Our core values of being CURIOSITY DRIVEN, EXCELLENCE FOCUSED, and PATIENT CENTERED guide our actions and decisions every day. These values help us achieve our purpose of making high-quality pharmaceuticals more affordable, more available, and better than ever before.
But what does it mean to be “excellence focused”? We asked our TIEFENBACHER API + INGREDIENTS Managing Director, Dr. Clemens Overlack, to elaborate:
“Excellence Focused” is one of the core values of Tiefenbacher Group. How does this commitment to excellence manifest in your day-to-day operations at TIEFENBACHER API & INGREDIENTS and how does it benefit your customers?
“An Active Pharmaceutical Ingredient (API) nowadays is a highly sophisticated product which has to conform to very stringent quality standards. From the beginning of our activities as distributors of APIs in 1963, we have thrived to ensure that these quality standards are always met. We supply from more than 100 carefully selected manufacturers around the world to whom we have had long-term relationships going back decades. These manufacturers are continuously monitored and audited by ourselves.
Our supply chain networks and infrastructure, for example a fully-fledged temperature-controlled warehouse with more than 1,500 pallet spaces as well as tightly controlled transportation routes, ensure that the quality of the APIs we supply is never compromised.
This focus on “better quality” ensures that our customers can fully rely on the standard of APIs we supply to them. It generates long-term trust which is vital in the supply of complex products such as APIs.”
Where do you see the future markets for APIs distributed by TIEFENBACHER API?
“Currently, TIEFENBACHER API supplies APIs to EU-based pharmaceutical companies with a focus on the German-speaking countries. However, quality standards for APIs are increasing worldwide. We therefore see a good chance to promote our high quality APIs to markets outside the EU, for example Middle East, Africa and Latin America. In all these markets we see strong growth.”
How does being a part of the TIEFENBACHER GROUP benefit TIEFENBACHER API?
“We already supply our high-quality APIs not only to external customers, but also to the group. At the same time, the technical and regulatory expertise available in the group helps us in our sourcing activities. We also develop strong networks through the group and can leverage this high expertise as well as the extended supplier base with our customers.”
At Tiefenbacher Group, the focus on excellence is the foundation of our pioneering approach to healthcare. We are excited about the future and remain committed to improving patients´ lives globally.
Feel free to reach out for more insights into our journey or to join us in pioneering the future of healthcare!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com
